| # | Drug | Count |
|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 2149 |
| 1 | CYCLOPHOSPHAMIDE | 1034 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 1034 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1034 |
| 4 | FLUDARABINE PHOSPHATE | 854 |
| 5 | DEXAMETHASONE 1.5 MG | 620 |
| 6 | DEXAMETHASONE | 619 |
| 7 | BREXUCABTAGENE AUTOLEUCEL | 604 |
| 8 | RITUXIMAB | 428 |
| 9 | TOCILIZUMAB | 424 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BREXUCABTAGENE AUTOLEUCEL | 604 | 0.2799 |
| 1 | AXICABTAGENE CILOLEUCEL | 2149 | 0.2115 |
| 2 | LISOCABTAGENE MARALEUCEL | 168 | 0.1918 |
| 3 | IDECABTAGENE VICLEUCEL | 197 | 0.1587 |
| 4 | TECLISTAMAB-CQYV | 211 | 0.0887 |
| 5 | EPCORITAMAB-BYSP | 108 | 0.0807 |
| 6 | TALQUETAMAB-TGVS | 102 | 0.0685 |
| 7 | CILTACABTAGENE AUTOLEUCEL | 388 | 0.0591 |
| 8 | GLOFITAMAB | 156 | 0.0576 |
| 9 | BLINATUMOMAB | 242 | 0.0226 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 2149 | 0.2115 |
| 1 | Interleukin-6 Antagonist [EPC] | 47 | 0.0724 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 264 | 0.0653 |
| 3 | Interferon gamma Blocker [EPC] | 5 | 0.0211 |
| 4 | CD22-directed Immunoconjugate [EPC] | 34 | 0.0114 |
| 5 | Interleukin-1 Receptor Antagonist [EPC] | 170 | 0.0101 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 51 | 0.0087 |
| 7 | Lymphocyte Growth Factor [EPC] | 10 | 0.0079 |
| 8 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 4 | 0.0066 |
| 9 | Echinocandin Antifungal [EPC] | 48 | 0.0058 |